share_log

Alimera Sciences Analyst Ratings

Alimera Sciences Analyst Ratings

Alimera Sciences分析师评级
Benzinga Analyst Ratings ·  2022/11/21 08:32
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/21/2022 6% Alliance Global Partners $11 → $4.5 Downgrades Buy → Neutral
07/28/2022 111.99% HC Wainwright & Co. $8 → $9 Maintains Buy
05/10/2022 88.44% HC Wainwright & Co. $10 → $8 Maintains Buy
02/25/2022 135.55% HC Wainwright & Co. $12 → $10 Maintains Buy
08/16/2021 182.66% HC Wainwright & Co. $16 → $12 Maintains Buy
04/15/2021 276.88% HC Wainwright & Co. $14 → $16 Maintains Buy
04/14/2020 229.77% HC Wainwright & Co. $15 → $14 Reiterates → Buy
04/07/2020 253.32% B. Riley Securities $24 → $15 Maintains Buy
11/18/2019 253.32% HC Wainwright & Co. $1 → $15 Maintains Buy
10/31/2019 -76.45% HC Wainwright & Co. $1.5 → $1 Maintains Buy
05/28/2019 -29.34% Craig-Hallum → $3 Initiates Coverage On → Buy
06/29/2018 -35.22% B. Riley Securities → $2.75 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
11/21/2022 6% 联盟全球合作伙伴 $11 → $4.5 评级下调 购买→中性
07/28/2022 111.99% HC Wainwright公司 $8 → $9 维护
05/10/2022 88.44% HC Wainwright公司 $10 → $8 维护
02/25/2022 135.55% HC Wainwright公司 $12 → $10 维护
08/16/2021 182.66% HC Wainwright公司 $16 → $12 维护
04/15/2021 276.88% HC Wainwright公司 $14 → $16 维护
04/14/2020 229.77% HC Wainwright公司 $15 → $14 重申 →购买
04/07/2020 253.32% B.莱利证券 $24 → $15 维护
11/18/2019 253.32% HC Wainwright公司 $1 → $15 维护
10/31/2019 -76.45% HC Wainwright公司 $1.5 → $1 维护
05/28/2019 -29.34% 克雷格-哈勒姆 → $3 开始承保 →购买
06/29/2018 -35.22% B.莱利证券 → $2.75 开始承保 →购买

What is the target price for Alimera Sciences (ALIM)?

阿里梅拉科学公司(Alim)的目标价是多少?

The latest price target for Alimera Sciences (NASDAQ: ALIM) was reported by Alliance Global Partners on November 21, 2022. The analyst firm set a price target for $4.50 expecting ALIM to rise to within 12 months (a possible 6.00% upside). 4 analyst firms have reported ratings in the last year.

联盟全球合作伙伴于2022年11月21日报道了阿里梅拉科学公司(纳斯达克:ALIM)的最新目标价。这家分析公司将目标价定为4.50美元,预计Alim将在12个月内上涨(可能上涨6.00%)。去年有4家分析公司公布了评级。

What is the most recent analyst rating for Alimera Sciences (ALIM)?

Alimera Sciences(Alim)的最新分析师评级是什么?

The latest analyst rating for Alimera Sciences (NASDAQ: ALIM) was provided by Alliance Global Partners, and Alimera Sciences downgraded their neutral rating.

阿里梅拉科学公司(纳斯达克股票代码:ALIM)的最新分析师评级由联盟全球合作伙伴提供,阿里梅拉科学公司下调了其中性评级。

When is the next analyst rating going to be posted or updated for Alimera Sciences (ALIM)?

Alimera Sciences(Alim)的下一次分析师评级将于何时发布或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alimera Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alimera Sciences was filed on November 21, 2022 so you should expect the next rating to be made available sometime around November 21, 2023.

分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与Alimera Sciences的高管和客户交谈,以及收听收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。Alimera Sciences的上一次评级是在2022年11月21日提交的,所以你应该预计下一次评级将在2023年11月21日左右提供。

Is the Analyst Rating Alimera Sciences (ALIM) correct?

分析师对Alimera Sciences(Alim)的评级正确吗?

While ratings are subjective and will change, the latest Alimera Sciences (ALIM) rating was a downgraded with a price target of $11.00 to $4.50. The current price Alimera Sciences (ALIM) is trading at is $4.25, which is out of the analyst's predicted range.

虽然评级是主观的,并将发生变化,但最新的Alimera Sciences(Alim)评级被下调,目标价为11.00美元至4.50美元。Alimera Sciences(Alim)目前的交易价格为4.25美元,超出了分析师的预测区间。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发